View this email in your browser ([link removed])
AVAC Advocates' Network Logo March 14, 2025
Global Health Watch is a weekly newsletter breaking down critical developments in US policies and their impact on global health. Tailored for our partners in the US and around the world, this resource offers a concise analysis of the week’s events, supporting advocates to respond to threats, challenges and opportunities in this critical period of change in global health. 

This week's issue covers the latest developments in the AVAC vs. Department of State lawsuit, NIH’s termination of vaccine hesitancy research, new data revealing the deadly impact of foreign aid cuts on HIV, and renewed calls for African-led, sustainable health funding. Read on for more.


** AVAC vs. Department of State
------------------------------------------------------------

On Monday, US District Court Judge Amir Ali issued a 48-page ruling in AVAC vs. Department of State ([link removed]) and Global Health Council vs. Trump, the twin lawsuits against the foreign aid freeze. The ruling orders the government to pay for work already completed and to spend congressionally appropriated funds for foreign assistance. However, Judge Ali’s order did not reinstate the mass cancellations of aid grants, leaving thousands of lifesaving programs in limbo. Lauren Bateman, lead counsel on AVAC's case with Public Citizen Litigation Group, said “Today’s decision affirms a basic principle of our Constitution: the president is not a king. But we are painfully aware that, without unwinding the mass termination of foreign assistance awards, winning on the constitutional issues does not avert the humanitarian disaster caused by the Trump Administration’s freeze on foreign assistance. And it does not undo the damage that the freeze has already inflicted on
millions of vulnerable people across the world. Deaths will continue to mount. While the courts have an important role to play in standing up for the rule of law, Americans need more than just the courts. We need Congress, which has always supported foreign aid on a bipartisan basis, to assert itself.”

IMPLICATIONS: Secretary of State Marco Rubio confirmed that 5,200 USAID programs—about 83% of the agency’s overall work—have been terminated, citing “tens of billions of dollars” spent in ways that allegedly “did not serve US interests”. The new administration will retain about 1,000 programs under the State Department’s oversight. Even if some contracts are eventually reinstated, the State Department has already eliminated a significant majority of USAID’s work and tens of billions of dollars in Congressionally approved spending. It is unlikely implementing partners and programs will receive the funding they need to start back up and continue their critical work.

FOLLOW ALONG: You can follow along with progress on the case at, [link removed].

READ:
* Judge orders Trump to pay USAID partners, rejects 'unbounded' power ([link removed]) —Devex
* Trump Avoids Worst-Case Ruling in Lawsuit Over USAID Defunding ([link removed]) —Bloomberg


** NIH Cancels Grants on Vaccine Hesitancy
------------------------------------------------------------

In a sweeping move, the National Institutes of Health (NIH) is terminating or scaling back dozens of grants focused on vaccine hesitancy and boosting vaccine acceptance, citing “misalignment with NIH funding priorities.” It is unclear whether new Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr. directed the cuts—his longstanding anti-vaccine views are concerning, especially since the Centers for Disease Control and Prevention (CDC) was recently instructed to revisit the debunked link between vaccines and autism. The NIH is also canceling grants tied to transgender issues, diversity, equity, and inclusion, and research involving Chinese institutions, reflecting the administration’s broader push to cut spending and reshape federal research priorities.

IMPLICATIONS: Defunding these projects comes at a perilous time, given the reemergence of measles and declining immunization rates. By terminating research on vaccine hesitancy and acceptance, the NIH undermines efforts to build trust and increase uptake of essential prevention strategies, particularly among marginalized communities. This short-sighted approach risks widening existing health disparities and eroding decades of global progress toward equitable HIV prevention.

READ:
* NIH to ax grants on vaccine hesitancy, mRNA vaccines ([link removed]) —Science
* NIH to terminate or limit grants related to vaccine hesitancy and uptake ([link removed]) —Washington Post


** Reforming PEPFAR
------------------------------------------------------------

Researchers are proposing strategic reforms to PEPFAR, which is up for reauthorization later this month. The recommendations would trim PEPFAR program costs by 20% in five years, and transition financial responsibility to local governments in high-burden regions. They focus on ramping up long‐acting PrEP as a key component of HIV prevention. As highlighted in the opinion piece by Jirair Ratevosian ([link removed]) , PEPFAR has evolved far beyond its original “emergency plan,” becoming indispensable to global HIV prevention and treatment. Embracing these reforms, he writes, would ensure PEPFAR remains resilient and impactful amid rising infections, geopolitical strains, and domestic political uncertainty.

READ:
* It’s Time for PEPFAR to Embrace Reform ([link removed]) —Global Health Now
* By executive order: The likely deadly consequences associated with a 90-day pause in PEPFAR ([link removed]) funding ([link removed]) – Journal of the International AIDS Society


** The Impact of Funding Cuts and Frozen Aid
------------------------------------------------------------

Nearly two months into the dismantling of foreign aid and the research enterprise, the scale of the threat to vulnerable populations and global health is coming into sharper focus. New modeling data presented at CROI ([link removed]) shows that nearly one in five children under one with HIV who experienced a treatment interruption in 2024 died ([link removed]) , based on a review of over half a million children in US-funded PEPFAR programs. With major challenges to sustaining access to treatment since the new administration froze PEPFAR funds, the findings from this modeling study are a dire warning of the toll on lives to be expected from these policy changes. Meanwhile, clinical trials for new prevention tools, such as long-acting injectables and HIV
vaccines ([link removed]) , have been halted ([link removed]) or scaled back, while organizations that built local research capacity and trust with communities now face staff layoffs and funding shortfalls.

IMPLICATIONS: The loss of data from these canceled projects will undermine governments’ ability to sustain the HIV response, with or without U.S. support, and reduced investment in infectious disease research could drive up costs in the long run.

READ:
* US funding cuts imperil search for HIV vaccine ([link removed]) —Spotlight SA
* PEPFAR study shows the deadly impact of stopping children’s HIV treatment ([link removed]) —aidsmap


** Africa and Sustainable Health Funding
------------------------------------------------------------

Global health leaders are joining calls from civil society for African nations to break free from donor dependency by building self-sufficient, locally-driven health systems that prioritize their own needs and strategies. A rethinking of traditional aid models in favor of sustainable, equitable investments in health infrastructure and local research is needed and holding donor countries accountable for supporting true development rather than perpetuating reliance on external funding is imperative.

READ:
* After USAID: what now for aid and Africa?— ([link removed]) BMJ
* Africa's defining moment: the time to lead the HIV response is now ([link removed](25)00102-0/fulltext) —Lancet Global Health


** ICYMI, PxWire Special Edition
------------------------------------------------------------

In case you missed it, check out the special edition of PxWire, ([link removed]) which dives into the assault on global health and its devastating impact on HIV prevention—from crippling existing PrEP delivery to threatening the rollout of LEN for PrEP and paralyzing R&D.
Read PxWire ([link removed])


** What we're reading
------------------------------------------------------------
• Cuts to USAID-funded research another blow to global HIV response ([link removed]) —Devex
• US funding cuts imperil search for HIV vaccine ([link removed]) —Spotlight SA
• Opinion: Trump’s war on science imperils global development and cooperation ([link removed]) —Devex
• Tuberculosis Resurgent as Trump Funding Cut Disrupts Treatment Globally ([link removed]) —the New York Times
• Scoop: White House pulls CDC director nomination ([link removed]) —Axios

RESOURCES
• Impact of US funding cuts on the global AIDS response ([link removed]) —UNAIDS
• PEPFAR Watch ([link removed])
• Project 2025 Tracker ([link removed])
• Litigation Tracker ([link removed]) —Just Security 
• Federal Government Outlays ([link removed]) —DataETC

Many researchers and advocates are on their way home from San Francisco where the Conference on Retroviruses and Opportunistic Infections ([link removed]) (CROI) just wrapped up. The science showcased the great promise and importance of research and made clear just how much is at stake. You can read more about the promise of scientific advances against the backdrop of the US government’s priorities here ([link removed]) and here ([link removed]) .

In solidarity,

AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed])
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423 [email protected] (mailto:[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])